IMM 20.3% 35.5¢ immutep limited

Ann: Encouraging Phase II TACTI-002 data reported at SITC 2020, page-6

  1. 5,259 Posts.
    lightbulb Created with Sketch. 1641
    These results are "encouraging". In scientific terms that means potential twards phase III. I would be jumping the gun to say Ph III will happen "tomorrow". Phase II to ph III is THE bottleneck but crossing that bridge will be a major change in our position. Indications are good for now.

    Next news to look for is covid-19 results. IMO they will not have to be miraculous and they may not be either, but anything to show it is effective (statistically significant) to any degree is further confirmation of the science in BROADER terms/application ....


    Speaking of which ...

    The real game changer which I hope we will hear more of next year is application in autoimmune diseases ...
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.